secwatch.observer — SEC 8-K summary
======================================

Issuer:     Crinetics Pharmaceuticals, Inc. (CRNX)
CIK:        0001658247
Form:       8-K
Filed at:   2026-06-22T20:16:16+00:00
Accession:  0001658247-26-000044
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Crinetics shareholders elect three Class II directors, ratify PwC, approve say-on-pay
--------------------------------------------------------------------------------

- Elected Caren Deardorf (73.5M for), Weston Nichols (90.2M for), and Stephanie S. Okey (72.2M for) to 2029 terms.
- Ratified PricewaterhouseCoopers LLP as independent auditor for FY2026: 101.7M for, 342K against, 12.7K abstain.
- Advisory vote on named executive officer compensation approved: 91.7M for, 2.7M against, 2.6M abstain, 5.0M broker non-votes.
- Approximately 97% of outstanding shares (102,030,415) were represented at the meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1658247/000165824726000044/0001658247-26-000044-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1658247/000165824726000044/crnx-20260618.htm
  HTML page:      https://secwatch.observer/filing/0001658247-26-000044

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer